SAT0574 Performance of immunoglobulin M and G (IGM and IGG) antibodies against chikungunya virus (CHIKV) by enzyme-linked immunosorbent (ELISA) technique

Abstract

BackgroundCHIKV is suspected based on epidemiological and clinical criteria, however confirmation of the disease is only achieved by laboratory tests. Laboratory diagnosis is made by two approaches: the detection of viral RNA and identification of the specific immune response by serological methods. Serological tests are the most frequently used laboratory methods for the diagnosis of CHIKV. IgM is the first detected antibodies during 4 to 6 days after onset of symptoms followed by IgG. In Colombia, CHIKV's probable cases are not mandatory to be confirmed, so there is no standardization for laboratory confirmation testsObjectivesTo evaluate the performance of IgM and IgG antibodies against CHIKV in a cohort of patients with CHIKVMethodsIgM and IgG antibodies against CHIKV were measured by ELISA (AbcamÒ ab177835 and ab177835 anti-chikungunya virus IgM and IgG human ELISA kit, Cambridge, UK) technique in 604 patients with CHIKV suspicion. A typical case of CHIKV with high sensitivity and specificity obtained from a previous study was used as gold standard for diagnosis of CHIKV. Since CHIKV epidemic of 2014–2015 was the first to be reported in our country (Colombia), no second measurements of IgG were needed to confirmed infection.ResultsCut off point for IgG was 14,3 SU and for IgM was 11,2 SU. Mean values for IgG was 36,7 SU (±22,7) in patients with CHIKV and 8,6 SU (SD± 6,3) for IgM. Statistical significance was obtained for both IgG and IgM (p<0,0001) when comparing patients with and without CHIKV. Receiver operating characteristic (ROC) curves showed and area under the curve (AUC) of 0,81 for IgG and 0,65 for IgM (figure 1).ConclusionsOur study revealed a good performance of IgG and regular performance of IgM for the diagnosis of CHIKV in a cohort of CHIKV patients from Colombia's epidemic. Cut off points for both IgG and IgM were measured for future reference.Disclosure of InterestNone declared

The Performance of Nine Commercial Serological Screening Assays for the Diagnosis of Lyme Borreliosis: a Multicenter Modified Two-Gate Design Study

“…However, the ROC curves of the IgM assays had significantly lower AUCs than those of the IgG and IgM/IgG assays. These differences in assay performance based on antibody isotype are also observed for other infectious diseases, such as chronic pulmonary aspergillosis ( 18 ) and chikungunya virus ( 19 ).…”

Origins, pathophysiology, diagnosis, vaccination and prevention of Chikungunya virus

“…In a different study, IgM and IgG antibodies working against CHIKV were evaluated by using a specific ELISA technique in 604 patients. After comparing patients with CHIKV and without CHIKV, a statistical significance was observed for IgG and IgM (p <0.0001) [39].…”